Lacosamide Tablet, Film Coated
Product Images NDC 51407-724

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 51407-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-721-60lb (REV 12-22.jpg)

Lacosamide 50 mg tablets, USP, film-coated, in a bottle of 60 tablets by GSMS Incorporated. Label includes NDC 51407-721-60, barcode, and storage instructions. Manufactured by MSN Laboratories Private Limited; marketed by GSMS, Incorporated, Camarillo, CA.*

FDA Label Image

51407-722-60lb (REV 12-22.jpg)

Lacosamide 100 mg film-coated oral tablets label by Golden State Medical Supply, Inc. The label indicates 60 tablets per bottle with a National Drug Code (NDC) of 51407-722-60. It includes storage instructions, manufacturer (MSN Laboratories Private Limited), and marketing information. The label advises dispensing with a medication guide.*

FDA Label Image

51407-723-60lb (REV 12-22.jpg)

Lacosamide 150 mg tablets, USP, film-coated oral tablets. The label shows a package of 60 tablets labeled Rx only, with a purple "150 mg" strength box. It includes storage instructions (20°-25°C, excursions permitted between 15°-30°C) and directions for pharmacists to dispense with a medication guide. Manufactured by MSN Laboratories Private Limited and marketed by GSMS, Incorporated.*

FDA Label Image

51407-724-60lb (REV 12-22.jpg)

Label for Lacosamide 200 mg film-coated tablets, USP, with NDC 51407-724-60. The label indicates a package of 60 tablets for oral use. It includes storage instructions, a barcode, and warnings to keep medication out of children's reach. Manufactured by MSN Laboratories Private Limited and marketed by GSMS, Incorporated.*

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical structure of lacosamide, the active ingredient in the product LACOSAMIDE tablets. The diagram shows the molecular arrangement of atoms including carbon, hydrogen, oxygen, and nitrogen in lacosamide.*

FDA Label Image

Figure 1 (Lacosamide 02)

A bar graph titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' showing seizure reduction percentages across three studies (Study 2, Study 3, Study 4). Each study compares placebo with varying doses of lacosamide tablets, illustrating percent seizure reduction from baseline with doses labeled in mg/day and sample sizes.*

FDA Label Image

Figure 2 (Lacosamide 03)

A line graph depicting responder rate (equal to or greater improvement) on the vertical axis versus percent of patients on the horizontal axis for Lacosamide doses compared with placebo. The graph includes curves for placebo and Lacosamide at 200 mg/day, 400 mg/day, and 600 mg/day dosages, showing varying responder rates across patient percentages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.